Genomics BioSci & Tech. Co.,Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was TWD 396.14 million compared to TWD 419 million a year ago.

Net loss was TWD 168.07 million compared to net income of TWD 71.6 million a year ago. Basic loss per share from continuing operations was TWD 2.36 compared to basic earnings per share from continuing operations of TWD 1.13 a year ago. Diluted loss per share from continuing operations was TWD 2.36 compared to diluted earnings per share from continuing operations of TWD 1.13 a year ago.